Saphnelo (anifrolumab-fnia) - AstraZeneca
Anifrolumab in Refractory Discoid Lupus Erythematosus without Systemic Involvement: A Case Series of Five Patients. (PubMed, Acta Derm Venereol) - Sep 18, 2026 - No abstract available 
Journal • Discoid Lupus Erythematosus • Immunology • Inflammatory Arthritis • Lupus
http://www.ncbi.nlm.nih.gov/pubmed/42752899
 
Franziska Schauer; Jasmin Marschner
 
Sep 18, 2026
 
Prev Next